CT
PCRX icon

Colonial Trust’s Pacira BioSciences PCRX Stock Holding History

Colonial Trust’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.02K Hold
200
– – ﹤0.01% 864
2026
Q1 		$4.65K Buy
200
+30
+18% +$667 ﹤0.01% 856
2025
Q4 		$4.43K Buy
170
+52
+44% +$1.24K ﹤0.01% 867
2025
Q3 		$2.99K Buy
118
+25
+27% +$614 ﹤0.01% 945
2025
Q2 		$2.18K Buy
+93
New +$2.34K ﹤0.01% 971

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Colonial Trust's PCRX Position: Q2 2026 in Review

Colonial Trust held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 200 shares worth $5.02K. The position accounts for ﹤0.01% of the portfolio, ranked #864.

Colonial Trust first reported a position in PCRX in Q2 2025 and has held it in 5 quarters since. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Colonial Trust held 200 shares of Pacira BioSciences worth $5.02K as of Q2 2026.
  • Colonial Trust left its Pacira BioSciences share count unchanged in Q2 2026.
  • Pacira BioSciences made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #864 holding.
  • Colonial Trust first reported a position in Pacira BioSciences in Q2 2025 and has held it in 5 quarters since.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.